114 related articles for article (PubMed ID: 3166901)
1. Misonidazole reduces blood flow in two experimental murine tumours.
Murray JC; Randhawa VS
Br J Cancer; 1988 Aug; 58(2):128-32. PubMed ID: 3166901
[TBL] [Abstract][Full Text] [Related]
2. The effects of melphalan and misonidazole on the vasculature of a murine sarcoma.
Murray JC; Randhawa V; Denekamp J
Br J Cancer; 1987 Mar; 55(3):233-8. PubMed ID: 3552014
[TBL] [Abstract][Full Text] [Related]
3. Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice.
Lee FY; Workman P
Br J Cancer; 1983 May; 47(5):659-69. PubMed ID: 6849803
[TBL] [Abstract][Full Text] [Related]
4. Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide.
Law MP; Hirst DG; Brown JM
Br J Cancer; 1981 Aug; 44(2):208-18. PubMed ID: 7272187
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain.
Hirst DG; Brown JM; Hazlehurst JL
Br J Cancer; 1982 Jul; 46(1):109-16. PubMed ID: 7201845
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the action of alkylating agents by single high, or chronic low doses of misonidazole.
McNally NJ; Hinchliffe M; de Ronde J
Br J Cancer; 1983 Aug; 48(2):271-8. PubMed ID: 6882665
[TBL] [Abstract][Full Text] [Related]
7. Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
Fujimoto S; Kobayashi K; Takahashi M; Konno C; Kokubun M; Ohta M; Shrestha RD; Kiuchi S
Br J Cancer; 1992 Jan; 65(1):33-6. PubMed ID: 1733439
[TBL] [Abstract][Full Text] [Related]
8. Biodistribution of 14C-misonidazole as a probe for hypoxic cells in a murine tumor model.
Ikeda H; Takahashi I; Yonome I; Mitsuhashi N; Niibe H
Anticancer Res; 1998; 18(1A):241-5. PubMed ID: 9568084
[TBL] [Abstract][Full Text] [Related]
9. Vinca alkaloids: anti-vascular effects in a murine tumour.
Hill SA; Lonergan SJ; Denekamp J; Chaplin DJ
Eur J Cancer; 1993; 29A(9):1320-4. PubMed ID: 8343277
[TBL] [Abstract][Full Text] [Related]
10. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
11. Effect of clinical levels of misonidazole on the response of tumour and normal tissues in the mouse to alkylating agents.
Brown JM; Hirst DG
Br J Cancer; 1982 May; 45(5):700-8. PubMed ID: 7082556
[TBL] [Abstract][Full Text] [Related]
12. Skin sensitization by misonidazole: a demonstration of uniform mild hypoxia.
Stewart FA; Denekamp J; Randhawa VS
Br J Cancer; 1982 Jun; 45(6):869-77. PubMed ID: 7093121
[TBL] [Abstract][Full Text] [Related]
13. An investigation of the possibility of chemosensitization by clinically achievable concentrations of misonidazole.
Twentyman PR; Workman P
Br J Cancer; 1983 Feb; 47(2):187-94. PubMed ID: 6824566
[TBL] [Abstract][Full Text] [Related]
14. Influence of noradrenaline on local tumour blood flow.
Mattsson J; Alpsten M; Appelgren L; Peterson HI
Eur J Cancer (1965); 1980 Jan; 16(1):99-102. PubMed ID: 6987068
[No Abstract] [Full Text] [Related]
15. Effect of misonidazole or metronidazole pretreatment on the response of the RIF-1 mouse sarcoma to melphalan, cyclophosphamide, chlorambucil and CCNU.
Twentyman P; Workman P
Br J Cancer; 1982 Mar; 45(3):447-55. PubMed ID: 7073938
[TBL] [Abstract][Full Text] [Related]
16. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):861-70. PubMed ID: 7459220
[TBL] [Abstract][Full Text] [Related]
17. Effect of misonidazole pretreatment on nitrogen mustard-induced DNA cross-linking in mouse tissues in vivo.
Murray D; Meyn RE
Br J Cancer; 1984 Dec; 50(6):801-8. PubMed ID: 6498077
[TBL] [Abstract][Full Text] [Related]
18. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
[TBL] [Abstract][Full Text] [Related]
19. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
20. In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Tannock IF
Br J Cancer; 1980 Dec; 42(6):871-80. PubMed ID: 7459221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
